These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8491028)

  • 1. L-arginine in the clinical arena: tool or remedy?
    Lüscher TF; Haefeli WE
    Circulation; 1993 May; 87(5):1746-8. PubMed ID: 8491028
    [No Abstract]   [Full Text] [Related]  

  • 2. Positive and negative outcomes of L-arginine therapy in cardiovascular diseases.
    Herbaczyńska-Cedro K
    J Physiol Pharmacol; 1999 Dec; 50(4):653-60. PubMed ID: 10639015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L-arginine in the management of cardiovascular diseases.
    Cheng JW; Baldwin SN
    Ann Pharmacother; 2001 Jun; 35(6):755-64. PubMed ID: 11408995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic use of citrulline in cardiovascular disease.
    Romero MJ; Platt DH; Caldwell RB; Caldwell RW
    Cardiovasc Drug Rev; 2006; 24(3-4):275-90. PubMed ID: 17214603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. L-arginine transporters in cardiovascular disease: a novel therapeutic target.
    Chin-Dusting JP; Willems L; Kaye DM
    Pharmacol Ther; 2007 Dec; 116(3):428-36. PubMed ID: 17915331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. L-Arginine and its metabolites in kidney and cardiovascular disease.
    Popolo A; Adesso S; Pinto A; Autore G; Marzocco S
    Amino Acids; 2014 Oct; 46(10):2271-86. PubMed ID: 25161088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. L-arginine in cardiovascular disease: dream or reality?
    Tousoulis D; Antoniades C; Tentolouris C; Goumas G; Stefanadis C; Toutouzas P
    Vasc Med; 2002 Aug; 7(3):203-11. PubMed ID: 12553744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical pharmacology of L-arginine.
    Böger RH; Bode-Böger SM
    Annu Rev Pharmacol Toxicol; 2001; 41():79-99. PubMed ID: 11264451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of l-Arginine Supplementation with Markers of Endothelial Function in Patients with Cardiovascular or Metabolic Disorders: A Systematic Review and Meta-Analysis.
    Rodrigues-Krause J; Krause M; Rocha IMGD; Umpierre D; Fayh APT
    Nutrients; 2018 Dec; 11(1):. PubMed ID: 30577559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L-Arginine therapy in cardiovascular pathologies: beneficial or dangerous?
    Böger RH
    Curr Opin Clin Nutr Metab Care; 2008 Jan; 11(1):55-61. PubMed ID: 18090660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacodynamics of L-arginine.
    Böger RH
    Altern Ther Health Med; 2014; 20(3):48-54. PubMed ID: 24755570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: possible therapeutic targets?
    Rochette L; Lorin J; Zeller M; Guilland JC; Lorgis L; Cottin Y; Vergely C
    Pharmacol Ther; 2013 Dec; 140(3):239-57. PubMed ID: 23859953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Derangements of the nitric oxide synthase pathway, L-arginine, and cardiovascular diseases.
    Cooke JP; Dzau VJ
    Circulation; 1997 Jul; 96(2):379-82. PubMed ID: 9244195
    [No Abstract]   [Full Text] [Related]  

  • 14. L-Arginine improves vascular function by overcoming deleterious effects of ADMA, a novel cardiovascular risk factor.
    Böger RH; Ron ES
    Altern Med Rev; 2005 Mar; 10(1):14-23. PubMed ID: 15771559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asymmetric dimethylarginine, derangements of the endothelial nitric oxide synthase pathway, and cardiovascular diseases.
    Böger RH; Bode-Böger SM
    Semin Thromb Hemost; 2000; 26(5):539-45. PubMed ID: 11129410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and homoarginine (hArg): the ADMA, SDMA and hArg paradoxes.
    Tsikas D; Bollenbach A; Hanff E; Kayacelebi AA
    Cardiovasc Diabetol; 2018 Jan; 17(1):1. PubMed ID: 29301528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pathophysiological and clinical aspects of using L-arginine in cardiology and angiology].
    Valeev VV; Trashkov AP; Kovalenko AL; Vasil'ev AG
    Angiol Sosud Khir; 2016; 22(3):9-15. PubMed ID: 27626244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of L-arginine and selenium added to a hypocaloric diet enriched with legumes on cardiovascular disease risk factors in women with central obesity: a randomized, double-blind, placebo-controlled trial.
    Alizadeh M; Safaeiyan A; Ostadrahimi A; Estakhri R; Daneghian S; Ghaffari A; Gargari BP
    Ann Nutr Metab; 2012; 60(2):157-68. PubMed ID: 22517293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [L-Arginine and vascular health].
    Ströhle A; von Bibra H; Hahn A
    Med Monatsschr Pharm; 2016 Dec; 39(12):515-20. PubMed ID: 29979511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative stress and asymmetric dimethylarginine are associated with cardiovascular complications in hemodialysis patients: improvements by L-arginine intake.
    El-Mesallamy HO; Abdel Hamid SG; Gad MZ
    Kidney Blood Press Res; 2008; 31(3):189-95. PubMed ID: 18511874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.